SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sophiris Bio, Inc. (SPHS) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 49/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
33/100
Debt-to-Equity & liquidity
→ Health
估值概览 — SPHS
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.25
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2009 |
$-4.83 |
$0.00 |
$-7.54M |
- |
| 2010 |
$-2.44 |
$2.85M |
$-4.53M |
-159.1% |
| 2011 |
$-6.46 |
$0.00 |
$-15.16M |
- |
| 2012 |
$-7.57 |
$0.00 |
$-23.12M |
- |
| 2013 |
$-1.39 |
$5M |
$-11.15M |
-223% |
| 2014 |
$-1.90 |
$0.00 |
$-31.44M |
- |
| 2015 |
$-0.88 |
$0.00 |
$-14.89M |
- |
| 2016 |
$-0.50 |
$0.00 |
$-11.46M |
- |
| 2017 |
$-0.29 |
$0.00 |
$-8.84M |
- |
| 2018 |
$-0.25 |
$0.00 |
$-7.46M |
- |
